Bath & Body Works, Inc. (NYSE: BBWI) is a Consumer Cyclical company in the Specialty Retail industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
19.43
-0.93-4.59%
TA
Loading chart...
Snapshot
| Index | - | P/E | 5.87 | EPS (ttm) | 3.47 | Insider Own | 15.81% | Shs Outstand | 201.56M | Perf Week | 1.19% |
| Market Cap | 4.10B | Forward P/E | 7.17 | EPS next Y | 2.84 | Insider Trans | 0.00% | Shs Float | 189.71M | Perf Month | 2.16% |
| Enterprise Value | 8.00B | PEG | - | EPS next Q | 0.24 | Inst Own | - | Short Float | 8.61% | Perf Quarter | 5.49% |
| Income | 725.55M | P/S | 0.57 | EPS this Y | -23.68% | Inst Trans | - | Short Ratio | 2.74 | Perf Half Y | -8.45% |
| Sales | 7.24B | P/B | - | EPS next Y | 7.21% | ROA | 14.65% | Short Interest | 16.34M | Perf YTD | 1.39% |
| Book/sh | - | P/C | 3.55 | EPS next 5Y | 8.40% | ROE | -52.38% | 52W High | 30.83 -37.00% | Perf Year | -30.06% |
| Cash/sh | - | P/FCF | 4.51 | EPS past 3/5Y | -3.63% 0.46% | ROIC | 24.40% | 52W Low | 13.62 42.58% | Perf 3Y | -44.96% |
| Dividend Est. | 0.80 (4.12%) | EV/EBITDA | 5.61 | Sales past 3/5Y | -1.20% 2.53% | Gross Margin | 43.19% | Volatility | 3.61% 3.88% | Perf 5Y | -68.54% |
| Dividend TTM | 0.80 (4.12%) | EV/Sales | 1.10 | EPS Y/Y TTM | -3.88% | Oper. Margin | 15.85% | ATR (14) | 0.88 | Perf 10Y | -65.84% |
| Dividend Ex-Date | Jun 05, 2026 | Quick Ratio | 0.81 | Sales Y/Y TTM | -0.85% | Profit Margin | 10.03% | RSI (14) | 49.68 | Recom | 2.64 |
| Dividend Gr. 3/5Y | 0.00% 26.96% | Current Ratio | 1.38 | EPS Q/Q | -34.69% | SMA20 | -0.02% | Beta | 1.36 | Target Price | 21.75 |
| Payout | 22.56% | Debt/Eq | - | Sales Q/Q | -3.23% | SMA50 | 0.50% | Rel Volume | 0.80 | Prev Close | 20.36 |
| Employees | 60,735 | LT Debt/Eq | -3.50 | Earnings | Aug 27 | SMA200 | -0.92% | Avg Volume | 5.67M | Price | 19.43 |
| IPO Date | Apr 01, 1982 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 9.81% 1.20% | Net Debt/EBITDA | 2.73 | Volume | 4,533,062 | Change | -4.59% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-28-26 | Reiterated | Jefferies | Hold | $24 → $23 |
| Jul-08-26 | Downgrade | Goldman Sachs | Neutral → Sell | $23 → $19 |
| Jul-06-26 | Resumed | Morgan Stanley | Equal Weight | $18 → $22 |
| Jun-23-26 | Reiterated | Wells Fargo | Overweight | $25 → $26 |
| May-28-26 | Reiterated | Telsey Advisory Group | Market Perform | $17 → $22 |
| May-28-26 | Reiterated | Barclays | Equal Weight | $20 → $23 |
| May-28-26 | Reiterated | Goldman Sachs | Neutral | $17 → $23 |
| May-20-26 | Reiterated | UBS | Neutral | $22 → $19 |
| May-15-26 | Reiterated | Piper Sandler | Overweight | $39 → $20 |
| Feb-23-26 | Reiterated | UBS | Neutral | $21 → $22 |
Latest News
Aug-07-26
Aug-04-26
Aug-04-2601:10PM
Jul-30-26
Jul-28-26
Jul-27-26
Jul-20-26
Jul-20-2606:47PM
Jul-16-26
Jul-15-26
Jul-13-26
Jul-06-26
10:40AM
09:00AM
Jun-28-26
Jun-28-2603:32AM
Jun-26-26
Company
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 1/31/2026 | FY 2024 2/1/2025 | FY 2023 2/3/2024 | FY 2022 1/28/2023 | FY 2021 1/29/2022 | FY 2020 1/30/2021 | FY 2019 1/31/2020 | FY 2018 1/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,245 | 7,291 | 7,307 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 4,116 | 4,102 | 4,073 | — | — | — | — | — | — | |
| Gross Profit | 3,129 | 3,189 | 3,234 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,981 | 2,063 | 1,968 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Operating Income | 1,148 | 1,126 | 1,266 | — | — | — | — | — | — | |
| Interest Expense | 274 | 276 | 312 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 28 | 32 | 74 | — | — | — | — | — | — | |
| Net Income Before Taxes | 902 | 882 | 1,028 | — | — | — | — | — | — | |
| Income Taxes | 175 | 233 | 230 | — | — | — | — | — | — | |
| Consolidated Net Income | 727 | 649 | 798 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 727 | 649 | 798 | — | — | — | — | — | — | |
| Net Income | 727 | 649 | 798 | — | — | — | — | — | — | |
| EPS (Recurring) | 3.47 | 3.07 | 3.62 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.47 | 3.07 | 3.62 | — | — | — | — | — | — | |
| EPS (Diluted) | 3.47 | 3.07 | 3.61 | — | — | — | — | — | — | |
| EBITDA | 1,426 | 1,412 | 1,622 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 5.60 | 7.10 | 10.42 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.54 | 0.63 | 1.13 | — | — | — | — | — | — | |
| Gross Margin | 43.19 | 43.74 | 44.26 | — | — | — | — | — | — | |
| Operating Margin | 15.85 | 15.44 | 17.33 | — | — | — | — | — | — | |
| Net Margin | 10.03 | 8.90 | 10.92 | — | — | — | — | — | — | |
| Shares Outstanding | 202 | 212 | 220 | — | — | — | — | — | — | |
| Market Capitalization | 3,924 | 4,622 | 8,274 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Symancyk James Kevin | Director | Nov 24 '25 | Buy | 15.58 | 22,500 | 350,550 | 40,379 | Nov 25 |
| Nash Sarah E | Director | Nov 24 '25 | Buy | 15.58 | 10,000 | 155,800 | 285,522 | Nov 25 |
| Brady Lucy | Director | Nov 21 '25 | Buy | 14.40 | 3,470 | 49,962 | 17,482 | Nov 24 |
| Voskuil Steven E | Director | Nov 21 '25 | Buy | 15.04 | 20,000 | 300,700 | 33,925 | Nov 24 |
| STEINOUR STEPHEN D | Director | Nov 21 '25 | Buy | 14.86 | 6,700 | 99,529 | 48,175 | Nov 24 |
| Hondal Francis | Director | Nov 21 '25 | Buy | 14.99 | 3,343 | 50,128 | 21,554 | Nov 24 |
| Nash Sarah E | Director | Mar 10 '25 | Option Exercise | 0.00 | 127,288 | 0 | 282,896 | Mar 12 |
| Boswell Gina | Chief Executive Officer | Oct 09 '24 | Buy | 29.64 | 6,000 | 177,852 | 242,987 | Oct 11 |
| Nash Sarah E | Director | Jun 18 '24 | Sale | 41.50 | 48,000 | 1,992,120 | 149,202 | Jun 20 |
| Mazurek Thomas E. | Chief Supply Chain Officer | Mar 27 '24 | Option Exercise | 43.75 | 2,285 | 99,975 | 50,277 | Mar 28 |
| Mazurek Thomas E. | Chief Supply Chain Officer | Mar 27 '24 | Sale | 48.89 | 4,285 | 209,515 | 45,992 | Mar 28 |
| Nash Sarah E | Director | Mar 10 '24 | Option Exercise | 0.00 | 123,544 | 0 | 222,502 | Mar 12 |
| Rosen Julie | President, Retail | Mar 01 '24 | Sale | 45.83 | 12,361 | 566,476 | 12,361 | Mar 05 |
| Nash Sarah E | Director | Aug 20 '23 | Option Exercise | 0.00 | 3,770 | 0 | 99,565 | Aug 22 |
| Arlin Wendy C. | EVP and CFO | Mar 28 '23 | Option Exercise | 33.80 | 1,625 | 54,921 | 92,697 | Mar 29 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.